Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain

Psychopharmacology

Volumn 227, Issue 4, 2013, Pages 605-614

  Che, Yi ^c,d   Cui, Yong Hua ^d   Tan, Hua ^a   Andreazza, Ana C ^e   Young, L Trevor ^e   Wang, Jun Feng ^a,b,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Abstinence; Amphetamine; Depression; Oxidative stress; Rat frontal cortex; Rat hippocampus

Indexed keywords

AMPHETAMINE; REACTIVE OXYGEN METABOLITE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; FORCED SWIMMING TEST; FRONTAL CORTEX; HIPPOCAMPAL CA3 REGION; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; NEUROPATHOLOGY; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECOGNITION; SENSITIVITY ANALYSIS; WITHDRAWAL SYNDROME;

AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; LIPIDS; MALE; MOTOR ACTIVITY; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RNA; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 84878736358     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-2993-0     Document Type: Article

References (33)

1. Andreazza AC, Kauer-Sant'Anna M, Frey BN, Stertz L et al (2008) Effects of mood stabilizers on DNA damage in an animal model of mania. J Psychiatry Neurosci 33:516-524
2. Barr JL, Renner KJ, Forster GL (2010) Withdrawal from chronic amphetamine produces persistent anxiety-like behavior but temporally-limited reductions in monoamines and neurogenesis in the adult rat dentate gyrus. Neuropharmacology 59:395-405
3. Beer JS, Knight RT, D'Esposito M (2006) Controlling the integration of emotion and cognition: the role of frontal cortex in distinguishing helpful from hurtful emotional information. Psychol Sci 17:448-453
4. Bortolato M, Chen K, Shih JC (2008) Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev 60:1527-1533
5. Bregeon D, Sarasin A (2005) Hypothetical role of RNA damage avoidance in preventing human disease. Mutat Res 577:293-302
6. Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA et al (2001) Amphetamine induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49:81-96
7. Egashira T, Yamanaka Y (1993) Changes in monoamine oxidase activity in mouse brain associated with d-methamphetamine dependence and withdrawal. Biochem Pharmacol 46:609-614
8. Eyerman DJ, Yamamoto BK (2007) A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine. J Neurochem 103:1219-1227
9. Frey BN, Martins MR, Petronilho FC, Dal-Pizzol F, Quevedo J, Kapczinski F (2006a) Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord 8:275-280
10. Frey BN, Valvassori SS, Réus GZ, Martins MR, Petronilho FC, Bardini K, Dal-Pizzol F, Kapczinski F, Quevedo J (2006b) Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31:326-332
11. Jacobs D, Silverstone T (1986) Dextroamphetamine-induced arousal in human subjects as a model for mania. Psychol Med 16:323-329
12. Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52-58
13. Lenaz G (2012) Mitochondria and reactive oxygen species. Which role in physiology and pathology? Adv Exp Med Biol 942:93-136
14. Li Z, Wu J, Deleo CJ (2006) RNA damage and surveillance under oxidative stress. IUBMB Life 58:581-588
15. Lu W, Wolf ME (1997) Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration. Mol Brain Res 49:137-148
16. Macedo DS, Medeiros CD, Cordeiro RC, Sousa FC, Santos JV, Morais TA, Hyphantis TN, McIntyre RS, Quevedo J, Carvalho AF (2012) Effects of alpha-lipoic acid in an animal model of mania induced by D-amphetamine. Bipolar Disord 14:707-718
17. Maher P, Schubert D (2000) Signaling by reactive oxygen species in the nervous system. Cell Mol Life Sci 57:1287-1305
18. Nunomura A, Hofer T, Moreira PI et al (2009) RNA oxidation in Alzheimer disease and related neurodegenerative disorders. Acta Neuropathol 118:151-166
19. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic, San Diego
20. Petersen DR, Doorn JA (2004) Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 37:937-945
21. Richter-Levin G (2004) The amygdala, the hippocampus, and emotional modulation of memory. Neuroscientist 10:31-39
22. Robertson SD, Matthies HJ, Galli A (2009) A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol Neurobiol 39:73-80
23. Robinson TE, Camp DE (1987) Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion. Pharmacol Biochem Behav 26:821-827
24. Rossetti ZL, Hmaidan Y, Gessa GL (1992) Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 221:227-234
25. Rothman RB, Baumann MH (2006) Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann NY Acad Sci 1074:245-260
26. Shoptaw SJ, Kao U, Heinzerling K, Ling W (2009) Treatment for amphetamine withdrawal. Cochrane Database Syst Rev (2):CD003021. doi: 10.1002/14651858. CD003021.pub2
27. Skaper SD, Floreani M, Ceccon M et al (1999) Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. Ann NY Acad Sci 890:107-118
28. Tan H, Young LT, Shao L, Che Y, Honer WG, Wang JF (2012) Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex. Int J Neuropsychopharmacol 15:1275-1285
29. Trulson ME, Jacobs BL (1979) Chronic amphetamine administration to cats: behavioral and neurochemical evidence for decreased central serotonergic function. J Pharmacol Exp Ther 211:375-384
30. Valvassori SS, Moretti M, Kauer-Sant'Anna M, Roesler R, Petronilho F, Schwartsmann G, Kapczinski F, Dal-Pizzol F, Quevedo J (2010) Effects of a gastrin-releasing peptide receptor antagonist on D-amphetamine-induced oxidative stress in the rat brain. J Neural Transm 117:309-316
31. Vuong SM, Oliver HA, Scholl JL, Oliver KM, Forster GL (2010) Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism. Behav Brain Res 208:278-281
32. Walz JC, Frey BN, Andreazza AC, Ceresér KM, Cacilhas AA, Valvassori SS, Quevedo J, Kapczinski F (2008) Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania. J Psychiatr Res 42:416-421
33. Weiss F, Imperato A, Casu MA, Mascia MS, Gessa GL (1997) Opposite effects of stress on dopamine release in the limbic system of drug-naive and chronically amphetamine-treated rats. Eur J Pharmacol 337:219-222